It's been a rollercoaster for the CSL (ASX:CSL) share price over the last 6 months

CSL shares have been on the volatility train lately. Here's the details.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a bumpy ride for CSL Limited (ASX: CSL) shareholders this past 6 months.

For those who can't stomach extreme volatility, CSL shares wouldn't have been an appropriate choice over the last half year.

Nonetheless, CSL shareholders have been rewarded with a 10% return for holding in this time – almost double the S&P/ASX 200 index (ASX: XJO)'s gain of 5.7%.

Let's take a closer look at the trek CSL shares have been on lately.

Scared looking people on a rollercoaster ride representing volatility.

Image source: Getty Images

How has the CSL share price performed this past 6 months?

All in all, CSL shares have climbed $27 per share since April and now trade at $290, after sailing through choppy waters.

After rallying from $263 to $305 in months from April to June, a broker downgrade out of investment bank giant Citibank appears to have plagued the biotechnology company's share price at that point.

It fell sharply from the peak in June to a low of $275 by the following month. It popped again in mid-July after it appointed a new non-executive director, and then again in August after the release of its FY21 results.

In its earnings report, the company outperformed on guidance. It grew revenue 10% year on year to $10 billion and net profit by 10% as well to $2.3 billion – well above guidance of 3% to 8% growth.

CSL shares have been on the move since this event, nearly reaching their 52-week high by the end of September.

However, the CSL share price has taken a step backwards since then, in line with a selloff in the broader markets.

For instance, CSL shares have given away 7% this past month, whereas, at last check, the S&P/ASX 200 Health Care index (XHJ) has also slipped over 6% in this time.

Most of this has occurred in the last few weeks, where CSL shares have slipped over 7% since 23 September, in line with the broad index.

In light of this, it's clear to see that it's been a bumpy ride for CSL shareholders this past 6 months, with big swings in the value of their holdings.

Zooming out the CSL share price

Taking a longer-term view, the situation appears very much the same. The CSL share price has gained 2.4% this year to date, and 1.9% over the last 12 months.

Looking at its chart, however, over this time, there are big swings in price and a wide 12-month range of $316.68 to $246.

After rallying over the past 2 months, CSL's share price has cooled off lately and currently trades at its July 2021 levels of $290.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Retired couple hugging and laughing.
Healthcare Shares

A Budget announcement has put a rocket under this ASX aged care provider's shares

A shake up in the funding model will be a boost for this company.

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

What on earth's going on with Pro Medicus shares?

The quality stock is now driven heavily by expectations.

Read more »

A stressed businessman sits next to his briefcase with his head in his hands, while the ASX boards behind him show shares crashing.
52-Week Lows

CSL's collapse deepens. Why this ASX giant can't find a floor

CSL shares hit a 9-year low as new demand concerns emerge.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Prediction: CSL shares could surpass $265 in 2026

CSL shares are tumbling again on Wednesday. Here's what it'll take for the price to take a u-turn.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

Why are Cochlear shares down 36% today?

The medical device manufacturer has delivered a bitter pill for shareholders.

Read more »

Health professional working on his laptop.
Healthcare Shares

Are ASX healthcare shares the next to rally?

This sector has plenty of opportunity long term.

Read more »

a woman puts her fingers in her ears with a pained expression on her face with her eyes closed as though trying to block hearing bad news or an unpleasant loud noise.
Healthcare Shares

Cochlear cuts FY26 earnings outlook amid softer sales

Cochlear reduces its FY26 earnings guidance amid softer implant sales, ongoing challenges in key markets, and a focus on long-term…

Read more »